Product Introduction:
Zoryl MV 0.2/500/1 Tablet is an oral anti-diabetic medication used to manage type 2 diabetes mellitus in adults. It combines Glimepiride (a sulfonylurea), Metformin (a biguanide), and Voglibose (an alpha-glucosidase inhibitor). This triple therapy effectively controls blood glucose levels through multiple mechanisms: increasing insulin secretion, improving insulin sensitivity, and reducing glucose absorption in the intestine.
Uses:
-
Type 2 diabetes mellitus
-
Helps maintain blood sugar control
-
Prevents complications of uncontrolled diabetes
Benefits:
-
Effective triple drug combination for better glycemic control
-
Reduces fasting and post-meal blood sugar levels
-
Delays glucose absorption and insulin resistance
-
Helps prevent long-term diabetes complications
Composition (per tablet):
-
Glimepiride 1 mg
-
Metformin Hydrochloride 500 mg (SR – sustained release)
-
Voglibose 0.2 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Nausea, vomiting, stomach upset
-
Flatulence, abdominal discomfort
-
Metallic taste
-
Weight gain (mild, due to Glimepiride)
-
Rarely, lactic acidosis (with Metformin)
Safety Advice:
-
Take with meals to reduce GI side effects and risk of hypoglycemia
-
Regularly monitor blood sugar and kidney function
-
Avoid alcohol during treatment
-
Not recommended during pregnancy or breastfeeding without medical advice
-
Follow a balanced diet and exercise regimen along with medication
-
Inform your doctor if you experience any symptoms of low blood sugar (e.g., sweating, confusion, dizziness)
